German science and technology company Merck lowered mid-term targets for its Life Sciences and Healthcare businesses, ...

Merck said on Thursday its experimental antibody therapy, clesrovimab, demonstrated a 60.4% effectiveness in reducing ...

Merck KGaA is a science and technology company, which engages in the manufacture of pharmaceutical and chemical products. It operates through the following sectors: Healthcare, Life Science, and ...

EXEL is set to evaluate investigational zanzalintinib in combination with Merck;s Keytruda (pembrolizumab) and Welireg in head and neck cancer and renal cell carcinoma, respectively. ALAMEDA ...

Merck (NYSE: MRK) is a top pharmaceutical company coming off a good quarter that shows it is growing its top and bottom lines. Even with that growth, the stock still trades at a fairly modest ...

Merck & Co. Inc. closed $24.90 short of its 52-week high ($134.63), which the company achieved on June 25th.

Shares of Merck & Co. Inc. MRK slumped 0.79% to $109.40 Thursday, on what proved to be an all-around rough trading session ...

Sept 25 (Reuters) - Merck (MRK.N), opens new tab said on Wednesday a combination of its experimental drug and blockbuster therapy Keytruda failed a late-stage trial testing it in previously ...

The New York Knicks will have a new sponsor represented on their jersey patch for the 2024-25 season. Per The Athletic's Mike ...

European stocks closed higher on Thursday with investors cheering the European Central Bank's rate cut announcement, and digesting a ...

The U.S. Food and Drug Administration has put Novavax's trial of an experimental COVID-flu vaccine combination on hold after ...

Merck & Co. has picked up options on two Evaxion Biotech vaccine candidates, paying $3.2 million and dangling more than $1 billion in milestones for the chance to pick up preclinical prospects ...